$18.44
-0.23[-1.23%]
Last update: 1:46PM Get Real Time Here
Denali Therapeutics
(NASDAQ:DNLI)Denali Therapeutics Stock (NASDAQ:DNLI), Quotes and News Summary
Denali Therapeutics Stock (NASDAQ: DNLI) stock price, news, charts, stock research, profile.
| Open | $18.840 |
| Close | - |
| Volume / Avg. | 268.865K / 1.278M |
| Day Range | 18.300 - 18.950 |
| 52 Wk Range | 14.560 - 33.310 |
| Market Cap | $2.630B |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 57 |
| Short Interest | 7.87% |
| Days to Cover | 10.33 |
Recent News
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Denali Therapeutics (DNLI) stock?
You can purchase shares of Denali Therapeutics (NASDAQ: DNLI) through any online brokerage.
Who are Denali Therapeutics's (DNLI) competitors?
Other companies in Denali Therapeutics’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), Twist Bioscience (NASDAQ:TWST), Avidity Biosciences (NASDAQ:RNA), Ultragenyx Pharmaceutical (NASDAQ:RARE) and MoonLake (NASDAQ:MLTX).
What is the target price for Denali Therapeutics (DNLI) stock?
The latest price target for Denali Therapeutics (NASDAQ: DNLI) was reported by Wedbush on Wednesday, May 8, 2024. The analyst firm set a price target for 30.00 expecting DNLI to rise to within 12 months (a possible 60.86% upside). 22 analyst firms have reported ratings in the last year.
Current Stock Price for Denali Therapeutics (DNLI)?
The stock price for Denali Therapeutics (NASDAQ: DNLI) is $18.65 last updated Today at May 10, 2024 at 9:30 AM EDT.
Does Denali Therapeutics (DNLI) pay a dividend?
There are no upcoming dividends for Denali Therapeutics.
When is Denali Therapeutics (NASDAQ:DNLI) reporting earnings?
Denali Therapeutics’s Q2 earnings are confirmed for Tuesday, August 6, 2024.
Is Denali Therapeutics (DNLI) going to split?
There is no upcoming split for Denali Therapeutics.
What sector and industry does Denali Therapeutics (DNLI) operate in?
Denali Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.